Skip to content

Talphera, Inc. TLPH Liabilities Related To The Sale Of Future Payments

Liabilities Related To The Sale Of Future Payments at other companies

Kodiak Sciences Inc logo
Kodiak Sciences IncKOD
$100M0.0%
Geron logo
GeronGERN
$19.39M+24.8%
Arbutus Biopharma Corporation logo
Arbutus Biopharma CorporationABUS
$3.28M-25.7%
Ultragenyx Pharmaceutical logo
Ultragenyx PharmaceuticalRARE
$1.13B+42.1%
Elanco Animal Health Inc. logo
Elanco Animal Health Inc.ELAN
$309M
Ultragenyx Pharmaceutical logo
Ultragenyx PharmaceuticalRARE
$72M+25.5%

Other financials

Income statement

See full
Revenue--100%
Gross profit-$1.9M-52.7%
Operating income-$3.9M-35.4%
Net income-$2.6M+1.4%
EPS (diluted)-$0.10+37.5%

Balance sheet

See full
Cash & equivalents$3.8M-29.0%
Total debt$3.4M-79.7%
Total equity$18.5M+230%
Total assets$30.2M+101%

Cash flow

See full
Operating cash flow-$3.4M+2.0%
CapEx-
Free cash flow-$2.3M+42.9%

Valuation

See full
Market cap$53.46M+516%
P/S53,456.6×+53,135×

Profitability

See full
Gross margin-127.7%-136pp
Operating margin-1,451,600%-1,507,145pp
Net margin-1,425,300%-1,471,200pp
FCF margin-5,116.7%-6,779pp

Returns & leverage

See full
Return on equity-118.4%+15.4pp
Debt / equity0.2×
Current ratio5.3×+2.2×

Where this comes from

Reported directly by Talphera, Inc. in its filing.

Tagged under the XBRL concept tlph:LiabilitiesRelatedToTheSaleOfFuturePayments.

The official record: Talphera, Inc.’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Talphera, Inc.'s liabilities related to the sale of future payments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Talphera, Inc.'s liabilities related to the sale of future payments?
Talphera, Inc. (TLPH) reported liabilities related to the sale of future payments of $6.5M in Q1 2026.
How has Talphera, Inc.'s liabilities related to the sale of future payments changed year-over-year?
Talphera, Inc.'s liabilities related to the sale of future payments decreased by 0.4% year-over-year, from $6.53M to $6.5M.
What does liabilities related to the sale of future payments mean?
This represents the financial obligation arising from monetization agreements where the company receives upfront capital in exchange for a portion of future revenue streams or royalty payments. It reflects a form of non-dilutive financing used to fund research and development or commercialization efforts without issuing equity. Analysts evaluate this to understand the company's long-term revenue commitments and the impact of these arrangements on future cash flow availability.